Biotech executives pocket nearly $1 billion in M&A golden parachutes, 12 receive $35M+ payouts

An Endpoints News analysis identified a group of twelve biotech leaders who collectively earned close to $1 billion in exit compensation after selling their companies.

Each of these executives secured a parachute worth at least $35 million, bringing the total payout for the cohort to almost $1 billion.

The study notes that the biotech sector is experiencing an unprecedented wave of mergers and acquisitions, which has driven these large severance packages.

Industry observers see the payouts as a sign of the high stakes and lucrative outcomes that can accompany successful M&A activity in the drug space.